213 related articles for article (PubMed ID: 11340797)
1. Drooling in Parkinson's disease: a novel speech and language therapy intervention.
Marks L; Turner K; O'Sullivan J; Deighton B; Lees A
Int J Lang Commun Disord; 2001; 36 Suppl():282-7. PubMed ID: 11340797
[TBL] [Abstract][Full Text] [Related]
2. Is drooling secondary to a swallowing disorder in patients with Parkinson's disease?
Nóbrega AC; Rodrigues B; Torres AC; Scarpel RD; Neves CA; Melo A
Parkinsonism Relat Disord; 2008; 14(3):243-5. PubMed ID: 17892967
[TBL] [Abstract][Full Text] [Related]
3. Drooling in Parkinson's disease: A randomized controlled trial of incobotulinum toxin A and meta-analysis of Botulinum toxins.
Narayanaswami P; Geisbush T; Tarulli A; Raynor E; Gautam S; Tarsy D; Gronseth G
Parkinsonism Relat Disord; 2016 Sep; 30():73-7. PubMed ID: 27406786
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.
Mancini F; Zangaglia R; Cristina S; Sommaruga MG; Martignoni E; Nappi G; Pacchetti C
Mov Disord; 2003 Jun; 18(6):685-8. PubMed ID: 12784273
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin A as treatment for drooling saliva in PD.
Pal PK; Calne DB; Calne S; Tsui JK
Neurology; 2000 Jan; 54(1):244-7. PubMed ID: 10636161
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin is a useful treatment in excessive drooling in saliva.
Bhatia KP; Münchau A; Brown P
J Neurol Neurosurg Psychiatry; 1999 Nov; 67(5):697. PubMed ID: 10577041
[No Abstract] [Full Text] [Related]
7. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease.
Ondo WG; Hunter C; Moore W
Neurology; 2004 Jan; 62(1):37-40. PubMed ID: 14718694
[TBL] [Abstract][Full Text] [Related]
8. The option of sonographic guidance in Botulinum toxin injection for drooling in Parkinson's disease.
Jost WH
J Neural Transm (Vienna); 2016 Jan; 123(1):51-5. PubMed ID: 26138438
[TBL] [Abstract][Full Text] [Related]
9. Long-lasting benefits of botulinum toxin type B in Parkinson's disease-related drooling.
Lagalla G; Millevolte M; Capecci M; Provinciali L; Ceravolo MG
J Neurol; 2009 Apr; 256(4):563-7. PubMed ID: 19401804
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin injections for children with excessive drooling.
Hassin-Baer S; Scheuer E; Buchman AS; Jacobson I; Ben-Zeev B
J Child Neurol; 2005 Feb; 20(2):120-3. PubMed ID: 15794177
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
Lagalla G; Millevolte M; Capecci M; Provinciali L; Ceravolo MG
Mov Disord; 2006 May; 21(5):704-7. PubMed ID: 16440332
[TBL] [Abstract][Full Text] [Related]
12. Drooling in Parkinson's Disease: Evidence of a Role for Divided Attention.
Reynolds H; Miller N; Walker R
Dysphagia; 2018 Dec; 33(6):809-817. PubMed ID: 29785679
[TBL] [Abstract][Full Text] [Related]
13. Expiratory Muscle Strength Training for Drooling in Adults with Parkinson's Disease.
Cocks N; Rafols J; Embley E; Hill K
Dysphagia; 2022 Dec; 37(6):1525-1531. PubMed ID: 35171321
[TBL] [Abstract][Full Text] [Related]
14. Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson's disease?
Nóbrega AC; Rodrigues B; Torres AC; Enzo A; Melo A
J Neurol Sci; 2007 Feb; 253(1-2):85-7. PubMed ID: 17229441
[TBL] [Abstract][Full Text] [Related]
15. Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms.
Møller E; Karlsborg M; Bardow A; Lykkeaa J; Nissen FH; Bakke M
Acta Odontol Scand; 2011 May; 69(3):151-7. PubMed ID: 21198339
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin for treatment of parkinsonian sialorrhea.
Friedman A; Potulska A
Neurol Neurochir Pol; 2001; 35 Suppl 3():23-7. PubMed ID: 12001650
[TBL] [Abstract][Full Text] [Related]
17. Impact of progression of Parkinson's disease on drooling in various ethnic groups.
Rana AQ; Yousuf MS; Awan N; Fattah A
Eur Neurol; 2012; 67(5):312-4. PubMed ID: 22517489
[TBL] [Abstract][Full Text] [Related]
18. Does botulinum toxin injection in parotid glands interfere with the swallowing dynamics of Parkinson's disease patients?
Nóbrega AC; Rodrigues B; Melo A
Clin Neurol Neurosurg; 2009 Jun; 111(5):430-2. PubMed ID: 19181440
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology of diurnal drooling in Parkinson's disease.
Kalf JG; Munneke M; van den Engel-Hoek L; de Swart BJ; Borm GF; Bloem BR; Zwarts MJ
Mov Disord; 2011 Aug; 26(9):1670-6. PubMed ID: 21484876
[TBL] [Abstract][Full Text] [Related]
20. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy.
Savarese R; Diamond M; Elovic E; Millis SR
Am J Phys Med Rehabil; 2004 Apr; 83(4):304-11; quiz 312-4, 336. PubMed ID: 15024333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
